Nicotine receptor partial agonists for smoking cessation

Mostrar otras versiones (1)

BACKGROUND: Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). This is an update of a Cochrane Review firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Livingstone-Banks, Jonathan, Fanshawe, Thomas R, Thomas, Kyla H, Theodoulou, Annika, Hajizadeh, Anisa, Hartman, Lilian, Lindson, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169257/
https://www.ncbi.nlm.nih.gov/pubmed/37142273
http://dx.doi.org/10.1002/14651858.CD006103.pub8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169257/
https://www.ncbi.nlm.nih.gov/pubmed/37142273
http://dx.doi.org/10.1002/14651858.CD006103.pub8

Ejemplares similares